Innovation Zed Announces CE Mark of New Technology InsulCheck DOSE: An Add-on Device That Automatically Logs the Time and Dialled Dosage for Insulin Pen Users DUBLIN, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Innovation Zed, an Irish R&D company specialising in the design, development and manufacturing of medical technologies, announced today it has secured a...

Innovation Zed and SNAQ Collaborate to Improve Health Outcomes for People With Diabetes DUBLIN, May 30, 2022 (GLOBE NEWSWIRE) -- Innovation Zed, an Irish MedTech R&D company, today announced the signing of a global partnership and data integration agreement for its family of...

Innovation Zed Announce 2022 Launch of InsulCheck DOSE Add-on Technology for Insulin Pens DUBLIN, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Innovation Zed, developer of novel diabetes management technologies (the InsulCheck range), headquartered at NovaUCD, at University College Dublin, Ireland...

Innovation Zed Announce Non-Invasive Continuous Glucose Monitoring Project and Appointment of a New Researcher DUBLIN, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Innovation Zed Ltd., developer of novel diabetes technologies (the InsulCheck range), announced further advancement in their research of technologies for...